Tarsus Pharmaceuticals CEO Bobak R. Azamian reports $803,100 common share sale
TARS•Tarsus Pharmaceuticals President, CEO and Board Chair Bobak R. Azamian sold 10,000 common shares for $80.31 each on November 13, 2026, according to a Form 4 dated November 17.
1. Share sale
Azamian sold 10,000 common shares on November 13, 2026, at $80.31 per share, for a reported total of $803,100. Following the sale, he held 817,991 shares indirectly through a trust and 33,421 shares directly.




